Latest Balance Sheet News

Noble Helium has secured $12 million in a two-tranche placement to advance its North Rukwa helium project in Tanzania, positioning itself as a key player amid a global helium supply disruption caused by Middle East conflicts.

Galan Lithium has completed Phase 1 construction at Hombre Muerto West, secured A$40 million to expand production capacity by 30%, and is poised to begin lithium chloride concentrate shipments in H2 2026.

Pantoro Gold delivered 17,757 ounces of gold in Q3 2026, generated $88.4 million EBITDA, and approved a third underground mine, reinforcing its growth trajectory at Norseman.

RLF AgTech has posted its strongest trading period with $18.3 million revenue year-to-date and positive EBITDA in March, driven by a strategic reset under new CEO Stuart Upton and a $4.5 million capital raise.

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

Torque Metals has appointed the former Spartan Resources leadership team to drive growth at its Paris Gold Project, reporting strong high-grade drilling results that extend mineralisation well beyond current resource boundaries. An updated Mineral Resource Estimate is expected in Q2 2026, supported by a robust cash position.

Deep Yellow Limited has accelerated development at its flagship Tumas uranium project in Namibia, nearing construction readiness with significant engineering and earthworks milestones. Exploration success at the nearby Tinkas Prospect and strategic leadership appointments position the company well amid a strengthening uranium market.

DevEx Resources is gearing up for a major uranium drilling campaign in 2026 after expanding its Northern Territory footprint and securing nearly $39 million in fresh capital. Soil anomalies at Murphy West and strategic licence acquisitions set the stage for exploration in the McArthur Basin.

AuKing Mining has bolstered its project portfolio with the acquisition of a Tasmanian tin and silver licence and the Malawi-based Tundulu Rare Earths Project, supported by $5 million in recent equity placements.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

SenSen Networks reported a 17% increase in annual recurring revenue to $11 million and positive operating cash flow of $0.9 million in Q3 FY26 despite supply chain disruptions delaying some projects. The company’s full-year EBITDA is expected to improve significantly over FY25.

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.